These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16924531)

  • 21. Role of nutrition support during induction chemoradiation therapy in esophageal cancer.
    Sikora SS; Ribeiro U; Kane JM; Landreneau RJ; Lembersky B; Posner MC
    JPEN J Parenter Enteral Nutr; 1998; 22(1):18-21. PubMed ID: 9437649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
    Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
    Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
    J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer.
    Nakamura M; Iwahashi M; Nakamori M; Ishida K; Naka T; Iida T; Katsuda M; Tsuji T; Nakatani Y; Yamaue H
    Langenbecks Arch Surg; 2008 Mar; 393(2):127-33. PubMed ID: 18071746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
    Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
    Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
    Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
    Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
    Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.
    Laterza E; Mosciaro O; Urso US; Inaspettato G; Cordiano C
    Hepatogastroenterology; 1994 Jun; 41(3):278-82. PubMed ID: 7959554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
    Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
    Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
    Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
    Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications.
    Hirao M; Ando N; Tsujinaka T; Udagawa H; Yano M; Yamana H; Nagai K; Mizusawa J; Nakamura K;
    Br J Surg; 2011 Dec; 98(12):1735-41. PubMed ID: 21918956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of perioperative concurrent chemotherapy, gefitinib, and hyperfractionated radiation followed by maintenance gefitinib in locoregionally advanced esophagus and gastroesophageal junction cancer.
    Rodriguez CP; Adelstein DJ; Rice TW; Rybicki LA; Videtic GM; Saxton JP; Murthy SC; Mason DP; Ives DI
    J Thorac Oncol; 2010 Feb; 5(2):229-35. PubMed ID: 20009775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.